Summary | |
---|---|
Symbol | HMGB1 |
Name | high mobility group box 1 |
Aliases | HMG3; SBP-1; DKFZp686A04236; Sulfoglucuronyl carbohydrate binding protein; Amphoterin; high mobility group p ...... |
Chromosomal Location | 13q12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Nucleus Chromosome Cytoplasm Secreted Cell membrane Peripheral membrane protein Extracellular side Endosome Endoplasmic reticulum-Golgi intermediate compartment Note=In basal state predominantly nuclear. Shuttles between the cytoplasm and the nucleus (PubMed:12231511, PubMed:17114460). Translocates from the nucleus to the cytoplasm upon autophagy stimulation (PubMed:20819940). Release from macrophages in the extracellular milieu requires the activation of NLRC4 or NLRP3 inflammasomes (By similarity). Passively released to the extracellular milieu from necrotic cells by diffusion, involving the fully reduced HGMB1 which subsequently gets oxidized (PubMed:19811284). Also released from apoptotic cells (PubMed:16855214, PubMed:18631454). Active secretion from a variety of immune and non-immune cells such as macrophages, monocytes, neutrophils, dendritic cells and natural killer cells in response to various stimuli such as LPS and cytokines involves a nonconventional secretory process via secretory lysosomes (PubMed:12231511, PubMed:14532127, PubMed:15944249). Secreted by plasma cells in response to LPS (By similarity). Found on the surface of activated platelets (PubMed:11154118). An increased chromatin association is observed when associated with the adenovirus protein pVII (PubMed:27362237). |
Domain |
PF00505 HMG (high mobility group) box PF09011 HMG-box domain |
Function |
Multifunctional redox sensitive protein with various roles in different cellular compartments. In the nucleus is one of the major chromatin-associated non-histone proteins and acts as a DNA chaperone involved in replication, transcription, chromatin remodeling, V(D)J recombination, DNA repair and genome stability. Proposed to be an universal biosensor for nucleic acids. Promotes host inflammatory response to sterile and infectious signals and is involved in the coordination and integration of innate and adaptive immune responses. In the cytoplasm functions as sensor and/or chaperone for immunogenic nucleic acids implicating the activation of TLR9-mediated immune responses, and mediates autophagy. Acts as danger associated molecular pattern (DAMP) molecule that amplifies immune responses during tissue injury (PubMed:27362237). Released to the extracellular environment can bind DNA, nucleosomes, IL-1 beta, CXCL12, AGER isoform 2/sRAGE, lipopolysaccharide (LPS) and lipoteichoic acid (LTA), and activates cells through engagement of multiple surface receptors. In the extracellular compartment fully reduced HMGB1 (released by necrosis) acts as a chemokine, disulfide HMGB1 (actively secreted) as a cytokine, and sulfonyl HMGB1 (released from apoptotic cells) promotes immunological tolerance (PubMed:23519706, PubMed:23446148, PubMed:23994764, PubMed:25048472). Has proangiogdenic activity (By similarity). May be involved in platelet activation (By similarity). Binds to phosphatidylserine and phosphatidylethanolamide (By similarity). Bound to RAGE mediates signaling for neuronal outgrowth (By similarity). May play a role in accumulation of expanded polyglutamine (polyQ) proteins such as huntingtin (HTT) or TBP (PubMed:23303669, PubMed:25549101). ; FUNCTION: Nuclear functions are attributed to fully reduced HGMB1. Associates with chromatin and binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA, DNA-containing cruciforms or bent structures, supercoiled DNA and ZDNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity (PubMed:20123072). May have an enhancing role in nucleotide excision repair (NER) (By similarity). However, effects in NER using in vitro systems have been reported conflictingly (PubMed:19446504, PubMed:19360789). May be involved in mismatch repair (MMR) and base excision repair (BER) pathways (PubMed:15014079, PubMed:16143102, PubMed:17803946). May be involved in double strand break repair such as non-homologous end joining (NHEJ) (By similarity). Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS) (By similarity). In vitro can displace histone H1 from highly bent DNA (By similarity). Can restructure the canonical nucleosome leading to relaxation of structural constraints for transcription factor-binding (By similarity). Enhances binding of sterol regulatory element-binding proteins (SREBPs) such as SREBF1 to their cognate DNA sequences and increases their transcriptional activities (By similarity). Facilitates binding of TP53 to DNA (PubMed:23063560). Proposed to be involved in mitochondrial quality control and autophagy in a transcription-dependent fashion implicating HSPB1; however, this function has been questioned (By similarity). Can modulate the activity of the telomerase complex and may be involved in telomere maintenance (By similarity). ; FUNCTION: In the cytoplasm proposed to dissociate the BECN1:BCL2 complex via competitive interaction with BECN1 leading to autophagy activation (PubMed:20819940). Involved in oxidative stress-mediated autophagy (PubMed:21395369). Can protect BECN1 and ATG5 from calpain-mediated cleavage and thus proposed to control their proautophagic and proapoptotic functions and to regulate the extent and severity of inflammation-associated cellular injury (By similarity). In myeloid cells has a protective role against endotoxemia and bacterial infection by promoting autophagy (By similarity). Involved in endosomal translocation and activation of TLR9 in response to CpG-DNA in macrophages (By similarity). ; FUNCTION: In the extracellular compartment (following either active secretion or passive release) involved in regulation of the inflammatory response. Fully reduced HGMB1 (which subsequently gets oxidized after release) in association with CXCL12 mediates the recruitment of inflammatory cells during the initial phase of tissue injury; the CXCL12:HMGB1 complex triggers CXCR4 homodimerization (PubMed:22370717). Induces the migration of monocyte-derived immature dendritic cells and seems to regulate adhesive and migratory functions of neutrophils implicating AGER/RAGE and ITGAM (By similarity). Can bind to various types of DNA and RNA including microbial unmethylated CpG-DNA to enhance the innate immune response to nucleic acids. Proposed to act in promiscuous DNA/RNA sensing which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (By similarity). Promotes extracellular DNA-induced AIM2 inflammasome activation implicating AGER/RAGE (PubMed:24971542). Disulfide HMGB1 binds to transmembrane receptors, such as AGER/RAGE, TLR2, TLR4 and probably TREM1, thus activating their signal transduction pathways. Mediates the release of cytokines/chemokines such as TNF, IL-1, IL-6, IL-8, CCL2, CCL3, CCL4 and CXCL10 (PubMed:12765338, PubMed:18354232, PubMed:19264983, PubMed:20547845, PubMed:24474694). Promotes secretion of interferon-gamma by macrophage-stimulated natural killer (NK) cells in concert with other cytokines like IL-2 or IL-12 (PubMed:15607795). TLR4 is proposed to be the primary receptor promoting macrophage activation and signaling through TLR4 seems to implicate LY96/MD-2 (PubMed:20547845). In bacterial LPS- or LTA-mediated inflammatory responses binds to the endotoxins and transfers them to CD14 for signaling to the respective TLR4:LY96 and TLR2 complexes (PubMed:18354232, PubMed:21660935, PubMed:25660311). Contributes to tumor proliferation by association with ACER/RAGE (By similarity). Can bind to IL1-beta and signals through the IL1R1:IL1RAP receptor complex (PubMed:18250463). Binding to class A CpG activates cytokine production in plasmacytoid dendritic cells implicating TLR9, MYD88 and AGER/RAGE and can activate autoreactive B cells. Via HMGB1-containing chromatin immune complexes may also promote B cell responses to endogenous TLR9 ligands through a B-cell receptor (BCR)-dependent and ACER/RAGE-independent mechanism (By similarity). Inhibits phagocytosis of apoptotic cells by macrophages; the function is dependent on poly-ADP-ribosylation and involves binding to phosphatidylserine on the cell surface of apoptotic cells (By similarity). In adaptive immunity may be involved in enhancing immunity through activation of effector T cells and suppression of regulatory T (TReg) cells (PubMed:15944249, PubMed:22473704). In contrast, without implicating effector or regulatory T-cells, required for tumor infiltration and activation of T-cells expressing the lymphotoxin LTA:LTB heterotrimer thus promoting tumor malignant progression (By similarity). Also reported to limit proliferation of T-cells (By similarity). Released HMGB1:nucleosome complexes formed during apoptosis can signal through TLR2 to induce cytokine production (PubMed:19064698). Involved in induction of immunological tolerance by apoptotic cells; its pro-inflammatory activities when released by apoptotic cells are neutralized by reactive oxygen species (ROS)-dependent oxidation specifically on Cys-106 (PubMed:18631454). During macrophage activation by activated lymphocyte-derived self apoptotic DNA (ALD-DNA) promotes recruitment of ALD-DNA to endosomes (By similarity). |
Biological Process |
GO:0000737 DNA catabolic process, endonucleolytic GO:0001667 ameboidal-type cell migration GO:0001773 myeloid dendritic cell activation GO:0001776 leukocyte homeostasis GO:0001780 neutrophil homeostasis GO:0001818 negative regulation of cytokine production GO:0001819 positive regulation of cytokine production GO:0002200 somatic diversification of immune receptors GO:0002218 activation of innate immune response GO:0002221 pattern recognition receptor signaling pathway GO:0002224 toll-like receptor signaling pathway GO:0002250 adaptive immune response GO:0002262 myeloid cell homeostasis GO:0002263 cell activation involved in immune response GO:0002274 myeloid leukocyte activation GO:0002285 lymphocyte activation involved in immune response GO:0002286 T cell activation involved in immune response GO:0002287 alpha-beta T cell activation involved in immune response GO:0002292 T cell differentiation involved in immune response GO:0002293 alpha-beta T cell differentiation involved in immune response GO:0002294 CD4-positive, alpha-beta T cell differentiation involved in immune response GO:0002347 response to tumor cell GO:0002366 leukocyte activation involved in immune response GO:0002407 dendritic cell chemotaxis GO:0002418 immune response to tumor cell GO:0002424 T cell mediated immune response to tumor cell GO:0002437 inflammatory response to antigenic stimulus GO:0002443 leukocyte mediated immunity GO:0002449 lymphocyte mediated immunity GO:0002456 T cell mediated immunity GO:0002460 adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains GO:0002507 tolerance induction GO:0002521 leukocyte differentiation GO:0002548 monocyte chemotaxis GO:0002562 somatic diversification of immune receptors via germline recombination within a single locus GO:0002643 regulation of tolerance induction GO:0002683 negative regulation of immune system process GO:0002685 regulation of leukocyte migration GO:0002687 positive regulation of leukocyte migration GO:0002688 regulation of leukocyte chemotaxis GO:0002690 positive regulation of leukocyte chemotaxis GO:0002694 regulation of leukocyte activation GO:0002695 negative regulation of leukocyte activation GO:0002696 positive regulation of leukocyte activation GO:0002697 regulation of immune effector process GO:0002703 regulation of leukocyte mediated immunity GO:0002706 regulation of lymphocyte mediated immunity GO:0002709 regulation of T cell mediated immunity GO:0002757 immune response-activating signal transduction GO:0002758 innate immune response-activating signal transduction GO:0002764 immune response-regulating signaling pathway GO:0002819 regulation of adaptive immune response GO:0002822 regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains GO:0002831 regulation of response to biotic stimulus GO:0002834 regulation of response to tumor cell GO:0002837 regulation of immune response to tumor cell GO:0002840 regulation of T cell mediated immune response to tumor cell GO:0006265 DNA topological change GO:0006266 DNA ligation GO:0006282 regulation of DNA repair GO:0006298 mismatch repair GO:0006308 DNA catabolic process GO:0006309 apoptotic DNA fragmentation GO:0006310 DNA recombination GO:0006352 DNA-templated transcription, initiation GO:0006367 transcription initiation from RNA polymerase II promoter GO:0006874 cellular calcium ion homeostasis GO:0006875 cellular metal ion homeostasis GO:0006909 phagocytosis GO:0006914 autophagy GO:0006921 cellular component disassembly involved in execution phase of apoptosis GO:0007159 leukocyte cell-cell adhesion GO:0007162 negative regulation of cell adhesion GO:0007204 positive regulation of cytosolic calcium ion concentration GO:0007254 JNK cascade GO:0009306 protein secretion GO:0010506 regulation of autophagy GO:0010594 regulation of endothelial cell migration GO:0010596 negative regulation of endothelial cell migration GO:0010631 epithelial cell migration GO:0010632 regulation of epithelial cell migration GO:0010633 negative regulation of epithelial cell migration GO:0010950 positive regulation of endopeptidase activity GO:0010952 positive regulation of peptidase activity GO:0016444 somatic cell DNA recombination GO:0017055 negative regulation of RNA polymerase II transcriptional preinitiation complex assembly GO:0019439 aromatic compound catabolic process GO:0022407 regulation of cell-cell adhesion GO:0022408 negative regulation of cell-cell adhesion GO:0022409 positive regulation of cell-cell adhesion GO:0030098 lymphocyte differentiation GO:0030217 T cell differentiation GO:0030262 apoptotic nuclear changes GO:0030335 positive regulation of cell migration GO:0030336 negative regulation of cell migration GO:0030595 leukocyte chemotaxis GO:0031098 stress-activated protein kinase signaling cascade GO:0031333 negative regulation of protein complex assembly GO:0031349 positive regulation of defense response GO:0032069 regulation of nuclease activity GO:0032070 regulation of deoxyribonuclease activity GO:0032071 regulation of endodeoxyribonuclease activity GO:0032072 regulation of restriction endodeoxyribonuclease activity GO:0032103 positive regulation of response to external stimulus GO:0032392 DNA geometric change GO:0032423 regulation of mismatch repair GO:0032425 positive regulation of mismatch repair GO:0032609 interferon-gamma production GO:0032612 interleukin-1 production GO:0032613 interleukin-10 production GO:0032615 interleukin-12 production GO:0032635 interleukin-6 production GO:0032640 tumor necrosis factor production GO:0032649 regulation of interferon-gamma production GO:0032652 regulation of interleukin-1 production GO:0032653 regulation of interleukin-10 production GO:0032655 regulation of interleukin-12 production GO:0032675 regulation of interleukin-6 production GO:0032689 negative regulation of interferon-gamma production GO:0032732 positive regulation of interleukin-1 production GO:0032733 positive regulation of interleukin-10 production GO:0032735 positive regulation of interleukin-12 production GO:0032755 positive regulation of interleukin-6 production GO:0032872 regulation of stress-activated MAPK cascade GO:0032874 positive regulation of stress-activated MAPK cascade GO:0032943 mononuclear cell proliferation GO:0032944 regulation of mononuclear cell proliferation GO:0032946 positive regulation of mononuclear cell proliferation GO:0033151 V(D)J recombination GO:0034121 regulation of toll-like receptor signaling pathway GO:0034123 positive regulation of toll-like receptor signaling pathway GO:0034162 toll-like receptor 9 signaling pathway GO:0034163 regulation of toll-like receptor 9 signaling pathway GO:0034165 positive regulation of toll-like receptor 9 signaling pathway GO:0034655 nucleobase-containing compound catabolic process GO:0035710 CD4-positive, alpha-beta T cell activation GO:0035711 T-helper 1 cell activation GO:0036336 dendritic cell migration GO:0040013 negative regulation of locomotion GO:0040017 positive regulation of locomotion GO:0042088 T-helper 1 type immune response GO:0042093 T-helper cell differentiation GO:0042098 T cell proliferation GO:0042102 positive regulation of T cell proliferation GO:0042104 positive regulation of activated T cell proliferation GO:0042110 T cell activation GO:0042129 regulation of T cell proliferation GO:0043254 regulation of protein complex assembly GO:0043277 apoptotic cell clearance GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043281 regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043367 CD4-positive, alpha-beta T cell differentiation GO:0043370 regulation of CD4-positive, alpha-beta T cell differentiation GO:0043371 negative regulation of CD4-positive, alpha-beta T cell differentiation GO:0043388 positive regulation of DNA binding GO:0043410 positive regulation of MAPK cascade GO:0043534 blood vessel endothelial cell migration GO:0043535 regulation of blood vessel endothelial cell migration GO:0043537 negative regulation of blood vessel endothelial cell migration GO:0043542 endothelial cell migration GO:0044270 cellular nitrogen compound catabolic process GO:0045063 T-helper 1 cell differentiation GO:0045088 regulation of innate immune response GO:0045089 positive regulation of innate immune response GO:0045580 regulation of T cell differentiation GO:0045581 negative regulation of T cell differentiation GO:0045619 regulation of lymphocyte differentiation GO:0045620 negative regulation of lymphocyte differentiation GO:0045739 positive regulation of DNA repair GO:0045785 positive regulation of cell adhesion GO:0045862 positive regulation of proteolysis GO:0045898 regulation of RNA polymerase II transcriptional preinitiation complex assembly GO:0046006 regulation of activated T cell proliferation GO:0046328 regulation of JNK cascade GO:0046330 positive regulation of JNK cascade GO:0046631 alpha-beta T cell activation GO:0046632 alpha-beta T cell differentiation GO:0046634 regulation of alpha-beta T cell activation GO:0046636 negative regulation of alpha-beta T cell activation GO:0046637 regulation of alpha-beta T cell differentiation GO:0046639 negative regulation of alpha-beta T cell differentiation GO:0046651 lymphocyte proliferation GO:0046700 heterocycle catabolic process GO:0048771 tissue remodeling GO:0048872 homeostasis of number of cells GO:0050663 cytokine secretion GO:0050670 regulation of lymphocyte proliferation GO:0050671 positive regulation of lymphocyte proliferation GO:0050701 interleukin-1 secretion GO:0050704 regulation of interleukin-1 secretion GO:0050707 regulation of cytokine secretion GO:0050708 regulation of protein secretion GO:0050714 positive regulation of protein secretion GO:0050715 positive regulation of cytokine secretion GO:0050716 positive regulation of interleukin-1 secretion GO:0050798 activated T cell proliferation GO:0050863 regulation of T cell activation GO:0050865 regulation of cell activation GO:0050866 negative regulation of cell activation GO:0050867 positive regulation of cell activation GO:0050868 negative regulation of T cell activation GO:0050870 positive regulation of T cell activation GO:0050900 leukocyte migration GO:0050918 positive chemotaxis GO:0050920 regulation of chemotaxis GO:0050921 positive regulation of chemotaxis GO:0051047 positive regulation of secretion GO:0051052 regulation of DNA metabolic process GO:0051054 positive regulation of DNA metabolic process GO:0051098 regulation of binding GO:0051099 positive regulation of binding GO:0051101 regulation of DNA binding GO:0051103 DNA ligation involved in DNA repair GO:0051105 regulation of DNA ligation GO:0051106 positive regulation of DNA ligation GO:0051123 RNA polymerase II transcriptional preinitiation complex assembly GO:0051222 positive regulation of protein transport GO:0051249 regulation of lymphocyte activation GO:0051250 negative regulation of lymphocyte activation GO:0051251 positive regulation of lymphocyte activation GO:0051271 negative regulation of cellular component movement GO:0051272 positive regulation of cellular component movement GO:0051403 stress-activated MAPK cascade GO:0051480 regulation of cytosolic calcium ion concentration GO:0052547 regulation of peptidase activity GO:0052548 regulation of endopeptidase activity GO:0055074 calcium ion homeostasis GO:0060260 regulation of transcription initiation from RNA polymerase II promoter GO:0060326 cell chemotaxis GO:0060633 negative regulation of transcription initiation from RNA polymerase II promoter GO:0065004 protein-DNA complex assembly GO:0070302 regulation of stress-activated protein kinase signaling cascade GO:0070304 positive regulation of stress-activated protein kinase signaling cascade GO:0070371 ERK1 and ERK2 cascade GO:0070372 regulation of ERK1 and ERK2 cascade GO:0070374 positive regulation of ERK1 and ERK2 cascade GO:0070486 leukocyte aggregation GO:0070489 T cell aggregation GO:0070661 leukocyte proliferation GO:0070663 regulation of leukocyte proliferation GO:0070665 positive regulation of leukocyte proliferation GO:0070897 DNA-templated transcriptional preinitiation complex assembly GO:0071103 DNA conformation change GO:0071593 lymphocyte aggregation GO:0071674 mononuclear cell migration GO:0071675 regulation of mononuclear cell migration GO:0071677 positive regulation of mononuclear cell migration GO:0071706 tumor necrosis factor superfamily cytokine production GO:0071824 protein-DNA complex subunit organization GO:0072503 cellular divalent inorganic cation homeostasis GO:0072507 divalent inorganic cation homeostasis GO:0072604 interleukin-6 secretion GO:0090025 regulation of monocyte chemotaxis GO:0090026 positive regulation of monocyte chemotaxis GO:0090130 tissue migration GO:0090132 epithelium migration GO:0090305 nucleic acid phosphodiester bond hydrolysis GO:0097028 dendritic cell differentiation GO:0097194 execution phase of apoptosis GO:0097350 neutrophil clearance GO:0097529 myeloid leukocyte migration GO:1901361 organic cyclic compound catabolic process GO:1902105 regulation of leukocyte differentiation GO:1902106 negative regulation of leukocyte differentiation GO:1902107 positive regulation of leukocyte differentiation GO:1903037 regulation of leukocyte cell-cell adhesion GO:1903038 negative regulation of leukocyte cell-cell adhesion GO:1903039 positive regulation of leukocyte cell-cell adhesion GO:1903532 positive regulation of secretion by cell GO:1903706 regulation of hemopoiesis GO:1903707 negative regulation of hemopoiesis GO:1903708 positive regulation of hemopoiesis GO:1904951 positive regulation of establishment of protein localization GO:1990774 tumor necrosis factor secretion GO:2000116 regulation of cysteine-type endopeptidase activity GO:2000142 regulation of DNA-templated transcription, initiation GO:2000143 negative regulation of DNA-templated transcription, initiation GO:2000146 negative regulation of cell motility GO:2000147 positive regulation of cell motility GO:2000514 regulation of CD4-positive, alpha-beta T cell activation GO:2000515 negative regulation of CD4-positive, alpha-beta T cell activation GO:2000778 positive regulation of interleukin-6 secretion GO:2001020 regulation of response to DNA damage stimulus GO:2001022 positive regulation of response to DNA damage stimulus GO:2001056 positive regulation of cysteine-type endopeptidase activity GO:2001198 regulation of dendritic cell differentiation GO:2001200 positive regulation of dendritic cell differentiation |
Molecular Function |
GO:0000217 DNA secondary structure binding GO:0000400 four-way junction DNA binding GO:0000405 bubble DNA binding GO:0001530 lipopolysaccharide binding GO:0001786 phosphatidylserine binding GO:0003684 damaged DNA binding GO:0003697 single-stranded DNA binding GO:0005125 cytokine activity GO:0005543 phospholipid binding GO:0008134 transcription factor binding GO:0008301 DNA binding, bending GO:0016829 lyase activity GO:0019955 cytokine binding GO:0019956 chemokine binding GO:0019958 C-X-C chemokine binding GO:0042056 chemoattractant activity GO:0043566 structure-specific DNA binding GO:0050786 RAGE receptor binding GO:0070182 DNA polymerase binding GO:0070491 repressing transcription factor binding GO:0072341 modified amino acid binding GO:0097100 supercoiled DNA binding |
Cellular Component |
GO:0000793 condensed chromosome GO:0005793 endoplasmic reticulum-Golgi intermediate compartment GO:0017053 transcriptional repressor complex |
KEGG |
hsa03410 Base excision repair hsa04140 Regulation of autophagy |
Reactome |
R-HSA-166054: Activated TLR4 signalling R-HSA-211227: Activation of DNA fragmentation factor R-HSA-879415: Advanced glycosylation endproduct receptor signaling R-HSA-109581: Apoptosis R-HSA-140342: Apoptosis induced DNA fragmentation R-HSA-75153: Apoptotic execution phase R-HSA-1834949: Cytosolic sensors of pathogen-associated DNA R-HSA-3134963: DEx/H-box helicases activate type I IFN and inflammatory cytokines production R-HSA-168256: Immune System R-HSA-168249: Innate Immune System R-HSA-975871: MyD88 cascade initiated on plasma membrane R-HSA-975155: MyD88 dependent cascade initiated on endosome R-HSA-166166: MyD88-independent TLR3/TLR4 cascade R-HSA-166058: MyD88 R-HSA-6798695: Neutrophil degranulation R-HSA-5357801: Programmed Cell Death R-HSA-168928: RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways R-HSA-1810476: RIP-mediated NFkB activation via ZBP1 R-HSA-5686938: Regulation of TLR by endogenous ligand R-HSA-445989: TAK1 activates NFkB by phosphorylation and activation of IKKs complex R-HSA-168180: TRAF6 Mediated Induction of proinflammatory cytokines R-HSA-933542: TRAF6 mediated NF-kB activation R-HSA-975138: TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation R-HSA-937061: TRIF-mediated TLR3/TLR4 signaling R-HSA-168142: Toll Like Receptor 10 (TLR10) Cascade R-HSA-181438: Toll Like Receptor 2 (TLR2) Cascade R-HSA-168164: Toll Like Receptor 3 (TLR3) Cascade R-HSA-166016: Toll Like Receptor 4 (TLR4) Cascade R-HSA-168176: Toll Like Receptor 5 (TLR5) Cascade R-HSA-168181: Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168138: Toll Like Receptor 9 (TLR9) Cascade R-HSA-168179: Toll Like Receptor TLR1 R-HSA-168188: Toll Like Receptor TLR6 R-HSA-168898: Toll-Like Receptors Cascades R-HSA-1606322: ZBP1(DAI) mediated induction of type I IFNs |
Summary | |
---|---|
Symbol | HMGB1 |
Name | high mobility group box 1 |
Aliases | HMG3; SBP-1; DKFZp686A04236; Sulfoglucuronyl carbohydrate binding protein; Amphoterin; high mobility group p ...... |
Chromosomal Location | 13q12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between HMGB1 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
Literatures describing the relation between HMGB1 and anti-tumor immunity in human cancer.
|
Summary | |
---|---|
Symbol | HMGB1 |
Name | high mobility group box 1 |
Aliases | HMG3; SBP-1; DKFZp686A04236; Sulfoglucuronyl carbohydrate binding protein; Amphoterin; high mobility group p ...... |
Chromosomal Location | 13q12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of HMGB1 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | HMGB1 |
Name | high mobility group box 1 |
Aliases | HMG3; SBP-1; DKFZp686A04236; Sulfoglucuronyl carbohydrate binding protein; Amphoterin; high mobility group p ...... |
Chromosomal Location | 13q12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of HMGB1 in various data sets.
|
Points in the above scatter plot represent the mutation difference of HMGB1 in various data sets.
|
Summary | |
---|---|
Symbol | HMGB1 |
Name | high mobility group box 1 |
Aliases | HMG3; SBP-1; DKFZp686A04236; Sulfoglucuronyl carbohydrate binding protein; Amphoterin; high mobility group p ...... |
Chromosomal Location | 13q12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of HMGB1. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | HMGB1 |
Name | high mobility group box 1 |
Aliases | HMG3; SBP-1; DKFZp686A04236; Sulfoglucuronyl carbohydrate binding protein; Amphoterin; high mobility group p ...... |
Chromosomal Location | 13q12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of HMGB1. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by HMGB1. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | HMGB1 |
Name | high mobility group box 1 |
Aliases | HMG3; SBP-1; DKFZp686A04236; Sulfoglucuronyl carbohydrate binding protein; Amphoterin; high mobility group p ...... |
Chromosomal Location | 13q12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of HMGB1. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | HMGB1 |
Name | high mobility group box 1 |
Aliases | HMG3; SBP-1; DKFZp686A04236; Sulfoglucuronyl carbohydrate binding protein; Amphoterin; high mobility group p ...... |
Chromosomal Location | 13q12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of HMGB1 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | HMGB1 |
Name | high mobility group box 1 |
Aliases | HMG3; SBP-1; DKFZp686A04236; Sulfoglucuronyl carbohydrate binding protein; Amphoterin; high mobility group p ...... |
Chromosomal Location | 13q12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between HMGB1 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | HMGB1 |
Name | high mobility group box 1 |
Aliases | HMG3; SBP-1; DKFZp686A04236; Sulfoglucuronyl carbohydrate binding protein; Amphoterin; high mobility group p ...... |
Chromosomal Location | 13q12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting HMGB1 collected from DrugBank database. |
Details on drugs targeting HMGB1.
|